The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cancer vaccination trial with novel multiple peptides in previously treated advanced non-small cell lung cancer.
Takashi Hirose
No relevant relationships to disclose
Hidehiro Noda
No relevant relationships to disclose
Kentaro Okuda
No relevant relationships to disclose
Seiji Abe
No relevant relationships to disclose
Yuji Oto
No relevant relationships to disclose
Sojiro Kusumoto
No relevant relationships to disclose
Tomohide Sugiyama
No relevant relationships to disclose
Hiroo Ishida
No relevant relationships to disclose
Takao Shirai
No relevant relationships to disclose
Masanao Nakashima
No relevant relationships to disclose
Toshimitsu Yamaoka
No relevant relationships to disclose
Tohru Ohmori
No relevant relationships to disclose
Koji Yoshida
No relevant relationships to disclose
Yusuke Nakamura
No relevant relationships to disclose
Mitsuru Adachi
No relevant relationships to disclose